Funding pathways for Canadian medical physics research
Medical physics research in Canada sits at the intersection of healthcare, engineering, physical science, and patient-centred innovation. Projects can involve radiation therapy, diagnostic imaging, nuclear medicine, dosimetry, artificial intelligence, health technology assessment, or the safe introduction of new clinical systems. Because this work crosses disciplinary boundaries, researchers often need to look beyond a single funding agency. Learn more about Icebreaker.
The Canadian Medical Physics Research Funding Opportunities available to a project will depend on its scientific question, clinical setting, readiness level, and institutional affiliations. A laboratory developing a detector may fit a natural sciences or engineering competition, while a study evaluating treatment outcomes may be better suited to a health research program. Hospital-based investigators may also combine federal grants with provincial programs, industry partnerships, and internal innovation funds.
The archived 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists (COMP) offers a useful professional context for this funding search. Its program connected scientific presentations, clinical practice, examinations, business meetings, and networking. Those same connections remain important today: strong applications often grow from relationships between medical physicists, oncologists, radiologists, engineers, data scientists, and research administrators.
Start with the research question
A clear research question is the foundation of a competitive proposal. “Improving radiation therapy” is too broad for most competitions, while a question such as whether adaptive planning can reduce dose to a defined organ without compromising target coverage gives reviewers a measurable objective. The question should identify the clinical problem, the proposed technical contribution, and the evidence needed to change practice.
Applicants should then classify the project by maturity. Early-stage work may focus on proof of concept, algorithm development, phantom studies, or detector characterization. Translational research may require prospective validation, multi-centre testing, workflow analysis, or health economic evaluation. Each stage points toward different Canadian research funding sources and different expectations for preliminary data.
A project involving human participants also needs an early plan for research ethics, privacy, data governance, and regulatory review. These elements should not be added after the scientific narrative is complete. Reviewers want to see that the team understands how imaging data, treatment records, patient-reported outcomes, or biological samples will be collected and protected.
Match the sponsor to the project
CIHR is often relevant when the central aim concerns patient outcomes, disease prevention, clinical effectiveness, health services, or implementation. Medical physics proposals can be competitive when they explain how a technical advance will improve diagnosis, treatment quality, safety, access, or health equity. The physics must remain rigorous, but the application should also make the health significance unmistakable.
NSERC can be a strong fit for fundamental physics, instrumentation, imaging science, computational methods, materials, and engineering research. Discovery Grants may support investigator-led programs, while collaborative and training mechanisms can help build partnerships with hospitals or technology companies. A proposal should demonstrate why the work belongs within the agency’s mandate rather than simply describing a clinical application.
The Canada Foundation for Innovation supports research infrastructure rather than ordinary operating expenses. A new imaging platform, treatment verification system, high-performance computing environment, or specialized detector facility may require a coordinated institutional submission. Provincial agencies such as Alberta Innovates, Fonds de recherche du Québec, or programs associated with provincial cancer systems can provide additional routes, particularly for applied and translational projects.
Partnerships broaden the funding landscape. Mitacs can support trainee placements with industry or other organizations, while hospital foundations and cancer charities may fund clinically focused pilot studies. Companies may contribute equipment, software, data access, or cash, but agreements should preserve scientific independence, publication rights, and appropriate management of conflicts of interest.
Compare common funding routes
Funding decisions are shaped by scope, timing, eligibility, and the evidence expected at each stage. The following map is a starting point rather than a substitute for reading the current competition guidelines, since program names, deadlines, and eligible expenses can change.
| Funding route | Best suited to | Typical contribution to a project | Key preparation need |
|---|---|---|---|
| CIHR | Patient-oriented, clinical, health services, and implementation research | Operating funds, research personnel, data collection, analysis | Strong health impact and clinical collaborators |
| NSERC | Fundamental medical physics, engineering, algorithms, and instrumentation | Investigator-led research and trainee support | Clear fit with natural sciences or engineering |
| Canada Foundation for Innovation | Major equipment, facilities, and research infrastructure | Capital and infrastructure-related costs | Institutional coordination and sustainability plan |
| Provincial agencies | Regional innovation, translation, and health-system priorities | Pilot studies, applied research, and commercialization support | Alignment with provincial priorities |
| Mitacs and industry partnerships | Co-developed projects and trainee experiences | Internships, partner-supported research, and knowledge transfer | Defined partner role and deliverables |
| Hospital or cancer foundations | Clinically relevant local projects | Seed funding, feasibility work, and patient-centred studies | Practical outcomes and visible clinical value |
A staged strategy can reduce risk. An investigator might use a departmental or foundation award to generate preliminary data, apply to a larger federal competition for validation, and then seek infrastructure funding for scale-up. This progression gives reviewers evidence that the project is feasible and that each funding request has a distinct purpose.
Build a persuasive application
Reviewers need to understand why the problem matters, why the proposed method is credible, and what will change if the work succeeds. A concise significance section can connect a technical limitation to a patient or health-system consequence. For example, a dosimetry uncertainty may affect treatment confidence, quality assurance workload, access to specialized care, or the consistency of multi-centre trials.
Preliminary data should answer the most important feasibility questions. Useful evidence may include phantom measurements, retrospective image analysis, simulation results, prototype performance, reproducibility testing, or a small clinical workflow study. Negative or mixed results can also be valuable when they justify a refined hypothesis and show that the team understands the technical risks.
The team structure should reflect the whole project. A medical physicist may lead methodology and quality assurance, while a clinician defines the care pathway, a statistician develops the analysis plan, an engineer supports hardware, and a patient or public partner contributes to outcomes that matter in practice. Letters of collaboration should explain specific contributions rather than offering general support.
Knowledge translation should be concrete. Potential outputs include validated protocols, open software, clinical decision support, standards contributions, training resources, publications, or implementation guidance. A proposal becomes more credible when it explains who will use each output, how adoption will be evaluated, and what barriers could prevent the research from reaching routine care.
Use professional networks strategically
Scientific meetings are valuable places to identify collaborators and learn how researchers frame successful proposals. COMP’s archived event materials show how a professional meeting can bring together research presentations, clinical discussions, exhibitors, and informal interaction. Conversations around a poster or technical session may reveal a multi-centre dataset, a complementary method, or an investigator willing to serve as a co-applicant.
The event’s focus on abstracts also illustrates the importance of communicating focused results. A concise abstract about clinical dosimetry audits or intercomparisons can demonstrate a practical problem, a reproducible method, and a pathway to broader implementation. Researchers reviewing their own project narrative may find useful examples in these clinical dosimetry abstracts.
Networking should include trainees and emerging investigators. Student participation can lead to future collaborations, technical exchanges, and mentorship relationships that strengthen both grant development and career progression. Informal activities such as the archived student night reflect the role of professional community in creating durable research connections.
Plan the application before the deadline
A funding calendar should include internal review, partner approvals, ethics planning, budget development, and time for rewriting. Institutional research offices may require draft submissions several weeks before the sponsor deadline. Early contact can clarify indirect costs, eligible salaries, equipment rules, letters of support, and whether a hospital or university must act as the administering institution.
Budget logic matters as much as budget size. Each cost should be connected to a work package, milestone, or deliverable. A request for software, scanner time, research personnel, travel, or patient involvement should explain why that expense is necessary and how it supports the proposed outcomes. Overly broad budgets can make a feasible project appear underdeveloped.
Researchers preparing a Canadian medical physics funding application should prioritize the following actions:
- Define the clinical or scientific problem in one precise sentence.
- Identify the primary agency and at least one secondary funding route.
- Assemble collaborators who cover clinical, technical, statistical, and implementation needs.
- Generate preliminary evidence that addresses the proposal’s largest feasibility risk.
- Confirm eligibility, ethics requirements, institutional deadlines, and eligible expenses early.
A strong funding strategy grows from scientific focus, appropriate partnerships, and disciplined planning. Review current CIHR, NSERC, CFI, provincial, hospital, and partnership programs, then connect the opportunity to a project that can produce credible evidence and meaningful clinical value. Use professional meetings and COMP networks to find collaborators, share focused results, and move promising medical physics research from concept to funded work.